Searched for
JAPANESE PHARMA
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...30 May, 2026, 12.52 AM IST- After 50 hearings, court reserves judgement in Daiichi-Fortis caseThe Delhi High Court has reserved its judgment in a significant arbitration case. Japanese drug maker Daiichi Sankyo is seeking to enforce ...27 May, 2026, 01.15 AM IST
- IHH-Daiichi legal battle nears verdict on September 10A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...29 Apr, 2026, 12.06 AM IST
- GIFT Nifty jumps 110 points on Iran-US peace talk hopes; Nifty seen reclaiming 24K on MondayGIFT Nifty surged 110 points on hopes of renewed Iran-US peace talks, boosting sentiment after weak markets. Positive global cues could hel...24 Apr, 2026, 07.13 PM IST
- Global Markets | Japan's Nikkei climbs as AI optimism outweighs Mideast concernsJapanese stocks surged Monday, nearing a historic peak, fueled by booming AI sector enthusiasm that overshadowed Middle East tensions. Majo...20 Apr, 2026, 09.09 AM IST
- The yen connection: 4 Indian pharma stocks which benefit from the strength of Japanese yen with an upside potential of up to 15%Every event in the currency market has a twin impact, while some lose but there are others which also gain. But given the mayhem on the str...06 Aug, 2024, 03.51 PM IST
- Japan shares slip for third day; all eyes on US stimulus debateThe Nikkei share average lost 0.30% to close at 26,467.08. The broader Topix shed 0.11% to 1,758.81, after touching its lowest since Nov. 2...08 Dec, 2020, 01.47 PM IST
- Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...23 Sep, 2020, 10.40 AM IST
- Deal with Ranbaxy: Should Daiichi Sankyo have followed the Nemawashi way?A core value of Japanese business is trust. And this is where Daiichi Sankyo’s Ranbaxy problem may start to hurt India-Japan ties.17 Nov, 2013, 05.00 AM IST
- Claris transfers two businesses to Japan JV for Rs 1,050 crClaris will continue to hold a 20 per cent stake in the JV, while Otsuka and Mitsui will hold 60 and 20 per cent in it, respectively, a com...31 Jul, 2013, 10.54 PM IST
- Japanese pharma cos keen on tie-ups with Indian companiesA delegation of pharmaceutical firms from Japan's Toyama prefecture today indicated that Japanese companies are keen to collaborate with In...13 Feb, 2013, 06.51 PM IST
- India likely to press for more access to Japanese pharma marketThe CEPA between India and Japan came into effect from August 1 2011. Both the sides expects that it would boost bilateral trade.29 Apr, 2012, 01.58 PM IST
- Japan may open up to Indian genericsJapan has veered round to considering India’s demand to open up its over $100-billion pharmaceutical market to Indian generic, or off-paten...11 Jan, 2010, 04.54 AM IST
- Ranbaxy to shift admin to MumbaiRanbaxy Laboratories, India’s largest pharma company by sales, is looking to shift its marketing and administrative teams from its Gurgaon ...30 Jul, 2009, 12.23 AM IST
- Japan's Daiichi to set up manufacturing, research unitThe $8-billion Daiichi Sankyo Company, Japan’s second-largest pharma company, is in the process of setting up a full-fledged manufacturing ...05 Jan, 2008, 01.03 AM IST
- Lupin makes a leap into Japanese pharma marketLupin’s acquisition in Japan gives it a foothold in a large pharmaceutical market with relatively low generic penetration. Japan is the wor...11 Oct, 2007, 12.31 AM IST
- Zydus scouts for partners in Land of Rising SunThe company is in talks with 2-3 pharma companies and has earmarked an investment of about $25 million for its expansion plans in Japan.29 Mar, 2007, 02.10 AM IST
Load More
